Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

BACKGROUND: Alopecia areata (AA) is an autoimmune disease resulting in hair loss with devastating psychosocial consequences. Despite its high prevalence, there are no FDA-approved treatments for AA. Prior studies have identified a prominent interferon signature in AA, which signals through JAK molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbari, Ali, Dai, Zhenpeng, Xing, Luzhou, Cerise, Jane E., Ramot, Yuval, Berkun, Yackov, Sanchez, Gina A. Montealegre, Goldbach-Mansky, Raphaela, Christiano, Angela M., Clynes, Raphael, Zlotogorski, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486197/
https://www.ncbi.nlm.nih.gov/pubmed/26137574
http://dx.doi.org/10.1016/j.ebiom.2015.02.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486197/
https://www.ncbi.nlm.nih.gov/pubmed/26137574
http://dx.doi.org/10.1016/j.ebiom.2015.02.015

Ejemplares similares